A point-of-care rapid diagnostic test for tuberculosis (TB) has been developed by a multinational team of scientists led by researchers at Stellenbosch University.
“This low-cost screening test has the potential to significantly speed up TB diagnosis in resource-limited setting,” says co-inventor, Prof Gerhard Walzl of Stellenbosch University‘s Faculty of Medicine and Health Sciences. The test is conducted on blood obtained from a finger-prick and can make a TB diagnosis in less than an hour.
“Health care workers with minimal training will be able use the test at grass-roots level and get immediate access to screening test results,” says Walzl. The diagnostic test is a hand-held, battery-operated instrument that will measure chemicals in the blood of people with possible TB.
The device is currently in developmental phase and its accuracy and efficacy will be tested in five African countries over the next three years by the ScreenTB consortium, a team of TB experts from eight African and European partnering institutions.
Other recent advances in TB diagnostics have radically improved diagnostic times, but high costs and the sophisticated equipment required have made this technology inaccessible to many.
“People in remote areas with high TB incidence still do not benefit from the newer developments and face long diagnostic delays and often multiple return visits to clinics before they are diagnosed,” says Walzl.
The new test will be able to provide near-immediate results that will enable a person with TB to be diagnosed and started on treatment during a single visit to a health care facility.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Australia to help Pacific Islands tackle tuberculosison June 26, 2020 at 9:37 pm
The federal government is providing $8.3 million for research to prevent the spread of tuberculosis among the Pacific Islands.
- Corona could lead to 95,000 tuberculosis deaths in Indiaon June 26, 2020 at 5:00 pm
A recent study published in the European Respiratory Journal (ERJ) estimates that the COVID-19 pandemic could result in 95,000 people dying of tuberculosis in India. This has been estimated majorly ...
- St Vincent’s Hospital: Sydneysiders at risk after tuberculosis outbreakon June 26, 2020 at 1:13 pm
Hundreds of patients and staff members at St Vincent’s Hospital have been exposed to a tuberculosis outbreak after a cluster of five people tested positive to the disease.
- Tuberculosis cases linked to NSW hospitalon June 26, 2020 at 10:34 am
A Sydney hospital is working to identify staff, patients and members of the public who may have been exposed to tuberculosis after identifying a small cluster of cases at the facility. Genomic ...
- Indonesia should explore whether tuberculosis vaccine BCG can protect against COVID-19on June 26, 2020 at 9:38 am
Since 1999, Indonesia has carried out BCG vaccinations for children—due to a high risk of tuberculosis. It's estimated BCG coverage is at 92.2% for newly born infants (0-2 months). However ...
- Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescenceon June 26, 2020 at 8:13 am
The precise nature of the local immune responses in lung tuberculosis (TB) granulomas requires a comprehensive understanding of their environmental complexities. At its most basic level, a granuloma ...
- Tuberculosis cases and deaths predicted to spike due to COVID-19on June 24, 2020 at 1:09 pm
A new study estimates that at least 110,000 additional deaths from tuberculosis in China, India and South Africa unless health services maintained and strengthened.
- COVID-19 pandemic could increase the global burden of tuberculosison June 24, 2020 at 8:38 am
The global COVID-19 pandemic could significantly increase the global burden of tuberculosis (TB) due to disruptions to health services, and delays to diagnosis and treatment, according to new ...
- Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malariaon June 24, 2020 at 1:31 am
English Analysis on World and 6 other countries about Contributions, Disaster Management, Children, Women, Epidemic and more; published on 24 Jun 2020 by Global Fund ...
- Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosison June 16, 2020 at 2:12 am
Treatment of tuberculosis needs to be taken for several weeks, despite good potency of drugs in vitro. Here, the authors show that mesenchymal stem cells can harbor Mycobacterium tuberculosis ...
via Bing News